101 related articles for article (PubMed ID: 7477654)
1. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions.
Gotloib L; Waisbrut V; Shostak A; Kushnier R
Nephron; 1995; 70(4):466-77. PubMed ID: 7477654
[TBL] [Abstract][Full Text] [Related]
2. Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid.
Gotloib L; Wajsbrot V; Shostak A; Kushnier R
Nephron; 1996; 73(2):219-27. PubMed ID: 8773348
[TBL] [Abstract][Full Text] [Related]
3. Daily short exposure of cultured mesothelial cells to lactated, high-glucose, low-pH peritoneal dialysis fluid induces a low-profile regenerative steady state.
Shostak A; Pivnik K; Gotloib L
Nephrol Dial Transplant; 1996 Apr; 11(4):608-13. PubMed ID: 8671847
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of a glucose-free, acidic lactated solution for peritoneal dialysis evaluated by population analysis of mesothelium.
Wajsbrot V; Shostak A; Gotloib L; Kushnier R
Nephron; 1998; 79(3):322-32. PubMed ID: 9678434
[TBL] [Abstract][Full Text] [Related]
5. The cytochemical profile of visceral mesothelium under the influence of lactated-hyperosmolar peritoneal dialysis solutions.
Gotloib L; Shostak A; Wajsbrot V; Kuschnier R
Nephron; 1995; 69(4):466-71. PubMed ID: 7777114
[TBL] [Abstract][Full Text] [Related]
6. Osmotic agents hamper mesothelial repopulation as seen in the doughnut in vivo model.
Gotloib L; Wajsbrot V; Shostak A
Perit Dial Int; 2005 Feb; 25 Suppl 3():S26-30. PubMed ID: 16048251
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperosmolality upon the mesothelial monolayer exposed in vivo and in situ to a mannitol-enriched dialysis solution.
Gotloib L; Wajsbrot V; Shostak A; Kushnier R
Nephron; 1999; 81(3):301-9. PubMed ID: 10050085
[TBL] [Abstract][Full Text] [Related]
8. Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin.
Gotloib L; Wajsbrot V; Shostak A
Nephron; 2002 Sep; 92(1):142-55. PubMed ID: 12187097
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate neutralizes peritoneal dialysate cytotoxicity: maintained integrity and proliferation of cultured human mesothelial cells.
Brunkhorst R; Mahiout A
Kidney Int; 1995 Jul; 48(1):177-81. PubMed ID: 7564075
[TBL] [Abstract][Full Text] [Related]
10. Is introduction of the bicarbonate buffer in PD solution unavoidable?
Jörres A
Perit Dial Int; 1996; 16(5):444-5. PubMed ID: 8914173
[No Abstract] [Full Text] [Related]
11. Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.
Wu J; Yang X; Zhang YF; Wang YN; Liu M; Dong XQ; Fan JJ; Yu XQ
Clin Vaccine Immunol; 2010 May; 17(5):757-63. PubMed ID: 20200188
[TBL] [Abstract][Full Text] [Related]
12. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
13. Characterization of epithelial-to-mesenchymal transition of mesothelial cells in a mouse model of chronic peritoneal exposure to high glucose dialysate.
Aroeira LS; Loureiro J; González-Mateo GT; Fernandez-Millara V; del Peso G; Sánchez-Tomero JA; Ruiz-Ortega M; Bajo MA; López-Cabrera M; Selgas R
Perit Dial Int; 2008 Nov; 28 Suppl 5():S29-33. PubMed ID: 19008536
[TBL] [Abstract][Full Text] [Related]
14. Glucose-induced changes in the phenotype of human peritoneal mesothelial cells: effect of L-2-oxothiazolidine carboxylic acid.
Breborowicz A; Breborowicz M; Oreopoulos DG
Am J Nephrol; 2003; 23(6):471-6. PubMed ID: 14605496
[TBL] [Abstract][Full Text] [Related]
15. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
16. [Intracellular pH changes induced by sclerosing agents in peritoneal fibroblasts].
Soria M; Arrieta J; Ugarte I; Moina I; Guerra M; Escanero J
Nefrologia; 2004; 24(2):158-66. PubMed ID: 15219091
[TBL] [Abstract][Full Text] [Related]
17. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
18. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
Zareie M; Hekking LH; Welten AG; Driesprong BA; Schadee-Eestermans IL; Faict D; Leyssens A; Schalkwijk CG; Beelen RH; ter Wee PM; van den Born J
Nephrol Dial Transplant; 2003 Dec; 18(12):2629-37. PubMed ID: 14605288
[TBL] [Abstract][Full Text] [Related]
19. High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure.
Gotloib L; Shostak A; Wajsbrot V; Kushnier R
Nephron; 1999 Jun; 82(2):164-73. PubMed ID: 10364709
[TBL] [Abstract][Full Text] [Related]
20. Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients.
Fougeray S; Slingeneyer A; Bastide JM; Mion C; Bastide M
Adv Perit Dial; 1994; 10():235-40. PubMed ID: 7999836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
